+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Region: Trend Forecast and Growth Opportunity

  • ID: 4901742
  • Report
  • January 2020
  • Region: Global
  • 161 pages
  • Grace Market Data
1 of 4

Order now to receive an updated version of this report covering the impact of COVID-19.

Enquire Now

FEATURED COMPANIES

  • Astra Zeneca PLC
  • Biocon
  • Eli Lilly
  • Exir
  • Julphar
  • Novo Nordisk AS
  • MORE
Global human insulin market is expected to reach $53.16 billion by 2026, representing a 2019-2026 CAGR of 7.47%.

Highlighted with 83 tables and 87 figures, this 161-page report “Global Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global human insulin market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with estimates and forecast covering 2020-2026.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify global human insulin market in every aspect of the classification from perspectives of Product Type, Application, Distribution Channel, and Region.

Based on product type, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
  • Human Insulin Drugs
  • Human Insulin Delivery Devices
Based on product, the global Human Insulin Drugs market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
  • Modern Human Insulin (further segmented into Long-acting, Rapid- acting, Premixed by type; further segmented into Lantus, Apidra, Levemir, NovoRapid/ NovoLog, Novomix, Humalog, Others by brand)
  • Traditional Human Insulin (further segmented into Short-acting, Intermediate & Rapid-acting, Premixed by type; further segmented into Humulin, Insuman, Novolin/Actrapid/Insulatard by brand)
Based on product, the global Human Insulin Delivery Devices market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
  • Syringes
  • Pens (further segmented into Disposable, Reusable, Pen needles)
  • Pumps
  • Others
Based on application, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes and Prediabetes
Based on distribution channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Geographically, the following regions together with the listed national/local markets are fully investigated:
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
  • Europe (Germany, UK, France, Spain, Italy, Rest of Europe; Rest of Europe is further segmented into Russia, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
  • North America (U.S. and Canada)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • RoW (Saudi Arabia, UAE, South Africa)
For each of the aforementioned regions and countries, market analysis and revenue data are available for 2019-2026. The breakdown of all regional markets by country and split of major national markets by Product Type, Application, and Distribution Channel over the study years (2019-2026) are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global human insulin market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players:
  • Astra Zeneca PLC
  • Biocon
  • Eli Lilly
  • Exir
  • Julphar
  • Novo Nordisk AS
  • Pfizer
  • Sanofi Aventis
  • Sedico
  • Wockhardt
(Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Astra Zeneca PLC
  • Biocon
  • Eli Lilly
  • Exir
  • Julphar
  • Novo Nordisk AS
  • MORE
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 Segmentation of Global Market by Product Type
3.1 Market Overview by Product Type
3.2 Human Insulin Drugs
3.3 Human Insulin Delivery Devices

4 Segmentation of Global Human Insulin Drugs Market by Drug Product
4.1 Market Overview by Drug Product
4.2 Modern Human Insulin
4.2.1 Modern Human Insulin by Type
4.2.2 Modern Human Insulin by Brand
4.3 Traditional Human Insulin
4.3.1 Traditional Human Insulin by Type
4.3.2 Traditional Human Insulin by Brand

5 Segmentation of Global Human Insulin Delivery Devices Market by Device Product
5.1 Market Overview by Product
5.2 Syringes
5.3 Pens
5.4 Pumps
5.5 Other Devices

6 Segmentation of Global Market by Application
6.1 Market Overview by Application
6.2 Type 1 Diabetes
6.3 Type 2 Diabetes
6.4 Gestational Diabetes and Prediabetes

7 Segmentation of Global Market by Distribution Channel
7.1 Market Overview by Distribution Channel
7.2 Hospital Pharmacies
7.3 Retail Pharmacies
7.4 Online Pharmacies

8 Segmentation of Global Market by Region
8.1 Geographic Market Overview 2019-2026
8.2 North America Market 2019-2026 by Country
8.2.1 Overview of North America Market
8.2.2 U.S. Market
8.2.3 Canadian Market
8.3 European Market 2019-2026 by Country
8.3.1 Overview of European Market
8.3.2 Germany
8.3.3 UK
8.3.4 France
8.3.5 Spain
8.3.6 Italy
8.3.7 Rest of European Market
8.4 Asia-Pacific Market 2019-2026 by Country
8.4.1 Overview of Asia-Pacific Market
8.4.2 Japan
8.4.3 China
8.4.4 Australia
8.4.5 India
8.4.6 South Korea
8.4.7 Rest of APAC Region
8.5 Latin America Market 2019-2026 by Country
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Mexico
8.5.4 Rest of Latin America Market
8.6 Rest of World Market 2019-2026 by Country
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 Other National Markets

9 Competitive Landscape
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
  • Astra Zeneca PLC
  • Biocon
  • Eli Lilly
  • Exir
  • Julphar
  • Novo Nordisk AS
  • Pfizer
  • Sanofi Aventis
  • Sedico
  • Wockhardt
10 Investing in Global Market: Risk Assessment and Management
10.1 Risk Evaluation of Global Market
10.2 Critical Success Factors (CSFs)

List of Tables

Table 1. Snapshot of Global Human Insulin Market, 2019-2026
Table 2. Main Product Trends and Market Opportunities in Global Human Insulin Market
Table 3. Global Human Insulin Market by Product Type, 2019-2026, $ mn
Table 4. Global Human Insulin Drugs Market by Product, 2019-2026, $ mn
Table 5. Global Human Insulin Drugs Market: Modern Human Insulin by Type, 2019-2026, $ mn
Table 6. Global Human Insulin Drugs Market: Modern Human Insulin by Brand, 2019-2026, $ mn
Table 7. Global Human Insulin Drugs Market: Traditional Human Insulin by Type, 2019-2026, $ mn
Table 8. Global Human Insulin Drugs Market: Traditional Human Insulin by Brand, 2019-2026, $ mn
Table 9. Global Human Insulin Delivery Devices Market by Product, 2019-2026, $ mn
Table 10. Global Human Insulin Delivery Devices Market: Pens by Product, 2019-2026, $ mn
Table 11. Global Human Insulin Market by Application, 2019-2026, $ mn
Table 12. Global Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 13. Global Human Insulin Market by Region, 2019-2026, $ mn
Table 14. Leading National Human Insulin Market, 2019 and 2026, $ mn
Table 15. North America Human Insulin Market by Country, 2019-2026, $ mn
Table 16. U.S. Human Insulin Market by Product Type, 2019-2026, $ mn
Table 17. U.S. Human Insulin Market by Application, 2019-2026, $ mn
Table 18. U.S. Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 19. Canada Human Insulin Market by Product Type, 2019-2026, $ mn
Table 20. Canada Human Insulin Market by Application, 2019-2026, $ mn
Table 21. Canada Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 22. Europe Human Insulin Market by Country, 2019-2026, $ mn
Table 23. Germany Human Insulin Market by Product Type, 2019-2026, $ mn
Table 24. Germany Human Insulin Market by Application, 2019-2026, $ mn
Table 25. Germany Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 26. UK Human Insulin Market by Product Type, 2019-2026, $ mn
Table 27. UK Human Insulin Market by Application, 2019-2026, $ mn
Table 28. UK Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 29. France Human Insulin Market by Product Type, 2019-2026, $ mn
Table 30. France Human Insulin Market by Application, 2019-2026, $ mn
Table 31. France Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 32. Spain Human Insulin Market by Product Type, 2019-2026, $ mn
Table 33. Spain Human Insulin Market by Application, 2019-2026, $ mn
Table 34. Spain Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 35. Italy Human Insulin Market by Product Type, 2019-2026, $ mn
Table 36. Italy Human Insulin Market by Application, 2019-2026, $ mn
Table 37. Italy Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 38. Human Insulin Market in Rest of Europe by Country, 2019-2026, $ mn
Table 39. APAC Human Insulin Market by Country, 2019-2026, $ mn
Table 40. Japan Human Insulin Market by Product Type, 2019-2026, $ mn
Table 41. Japan Human Insulin Market by Application, 2019-2026, $ mn
Table 42. Japan Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 43. China Human Insulin Market by Product Type, 2019-2026, $ mn
Table 44. China Human Insulin Market by Application, 2019-2026, $ mn
Table 45. China Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 46. Australia Human Insulin Market by Product Type, 2019-2026, $ mn
Table 47. Australia Human Insulin Market by Application, 2019-2026, $ mn
Table 48. Australia Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 49. India Human Insulin Market by Product Type, 2019-2026, $ mn
Table 50. India Human Insulin Market by Application, 2019-2026, $ mn
Table 51. India Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 52. South Korea Human Insulin Market by Product Type, 2019-2026, $ mn
Table 53. South Korea Human Insulin Market by Application, 2019-2026, $ mn
Table 54. South Korea Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 55. Human Insulin Market in Rest of APAC by Country, 2019-2026, $ mn
Table 56. Latin America Human Insulin Market by Country, 2019-2026, $ mn
Table 57. Argentina Human Insulin Market by Product Type, 2019-2026, $ mn
Table 58. Argentina Human Insulin Market by Application, 2019-2026, $ mn
Table 59. Argentina Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 60. Brazil Human Insulin Market by Product Type, 2019-2026, $ mn
Table 61. Brazil Human Insulin Market by Application, 2019-2026, $ mn
Table 62. Brazil Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 63. Mexico Human Insulin Market by Product Type, 2019-2026, $ mn
Table 64. Mexico Human Insulin Market by Application, 2019-2026, $ mn
Table 65. Mexico Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 66. RoW Human Insulin Market by Country, 2019-2026, $ mn
Table 67. UAE Human Insulin Market by Product Type, 2019-2026, $ mn
Table 68. UAE Human Insulin Market by Application, 2019-2026, $ mn
Table 69. UAE Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 70. Saudi Arabia Human Insulin Market by Product Type, 2019-2026, $ mn
Table 71. Saudi Arabia Human Insulin Market by Application, 2019-2026, $ mn
Table 72. Saudi Arabia Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 73. South Africa Human Insulin Market by Product Type, 2019-2026, $ mn
Table 74. South Africa Human Insulin Market by Application, 2019-2026, $ mn
Table 75. South Africa Human Insulin Market by Distribution Channel, 2019-2026, $ mn
Table 76. Global Human Insulin Market by Key Vendor, 2019, $ mn
Table 77. Astra Zeneca PLC: Company Snapshot
Table 78. Astra Zeneca PLC: Business Segmentation
Table 79. Astra Zeneca PLC: Product Portfolio
Table 80. Astra Zeneca PLC: Revenue, 2016-2018, $ mn
Table 81. Astra Zeneca PLC: Recent Developments
Table 82. Risk Evaluation for Investing in Global Market, 2019-2026
Table 83. Critical Success Factors and Key Takeaways

List of Figures

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026
Figure 4. Global Human Insulin Market, 2019-2026, $ mn
Figure 5. Primary Drivers and Impact Factors of Global Human Insulin Market
Figure 6. Primary Restraints and Impact Factors of Global Human Insulin Market
Figure 7. Porter’s Fiver Forces Analysis of Global Human Insulin Market
Figure 8. Breakdown of Global Human Insulin Market by Product Type, 2019-2026, % of Revenue
Figure 9. Contribution to Global 2020-2026 Cumulative Revenue by Product Type, Value ($ mn) and Share (%)
Figure 10. Global Human Insulin Market: Human Insulin Drugs, 2019-2026, $ mn
Figure 11. Global Human Insulin Market: Human Insulin Delivery Devices, 2019-2026, $ mn
Figure 12. Breakdown of Global Human Insulin Drugs Market by Product, 2019-2026, % of Revenue
Figure 13. Contribution to Global Human Insulin Drugs Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%)
Figure 14. Global Human Insulin Market: Modern Human Insulin, 2019-2026, $ mn
Figure 15. Global Modern Human Insulin Market: Long-acting, 2019-2026, $ mn
Figure 16. Global Modern Human Insulin Market: Rapid- acting, 2019-2026, $ mn
Figure 17. Global Modern Human Insulin Market: Premixed, 2019-2026, $ mn
Figure 18. Global Modern Human Insulin Market: Lantus, 2019-2026, $ mn
Figure 19. Global Modern Human Insulin Market: Apidra, 2019-2026, $ mn
Figure 20. Global Modern Human Insulin Market: Levemir, 2019-2026, $ mn
Figure 21. Global Modern Human Insulin Market: NovoRapid/ NovoLog, 2019-2026, $ mn
Figure 22. Global Modern Human Insulin Market: Novomix, 2019-2026, $ mn
Figure 23. Global Modern Human Insulin Market: Humalog, 2019-2026, $ mn
Figure 24. Global Modern Human Insulin Market: Other Brands, 2019-2026, $ mn
Figure 25. Global Human Insulin Market: Traditional Human Insulin, 2019-2026, $ mn
Figure 26. Global Traditional Human Insulin Market: Short-acting, 2019-2026, $ mn
Figure 27. Global Traditional Human Insulin Market: Intermediate & Rapid-acting, 2019-2026, $ mn
Figure 28. Global Traditional Human Insulin Market: Premixed, 2019-2026, $ mn
Figure 29. Global Traditional Human Insulin Market: Humulin, 2019-2026, $ mn
Figure 30. Global Traditional Human Insulin Market: Insuman, 2019-2026, $ mn
Figure 31. Global Traditional Human Insulin Market: Novolin/Actrapid/Insulatard, 2019-2026, $ mn
Figure 32. Breakdown of Global Human Insulin Delivery Devices Market by Product, 2019-2026, % of Revenue
Figure 33. Contribution to Global Human Insulin Delivery Devices Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%)
Figure 34. Global Human Insulin Delivery Devices Market: Syringes, 2019-2026, $ mn
Figure 35. Global Human Insulin Delivery Devices Market: Pens, 2019-2026, $ mn
Figure 36. Global Human Insulin Delivery Devices Market: Pumps, 2019-2026, $ mn
Figure 37. Global Human Insulin Delivery Devices Market: Other Devices, 2019-2026, $ mn
Figure 38. Breakdown of Global Human Insulin Market by Application, 2019-2026, % of Revenue
Figure 39. Contribution to Global 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%)
Figure 40. Global Human Insulin Market: Type 1 Diabetes, 2019-2026, $ mn
Figure 41. Global Human Insulin Market: Type 2 Diabetes, 2019-2026, $ mn
Figure 42. Global Human Insulin Market: Gestational Diabetes and Prediabetes, 2019-2026, $ mn
Figure 43. Breakdown of Global Human Insulin Market by Distribution Channel, 2019-2026, % of Revenue
Figure 44. Contribution to Global 2020-2026 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%)
Figure 45. Global Human Insulin Market: Hospital Pharmacies, 2019-2026, $ mn
Figure 46. Global Human Insulin Market: Retail Pharmacies, 2019-2026, $ mn
Figure 47. Global Human Insulin Market: Online Pharmacies, 2019-2026, $ mn
Figure 48. Global Market Snapshot by Region
Figure 49. Geographic Spread of Worldwide Human Insulin Market, 2019-2026, % of Revenue
Figure 50. Contribution to Global 2020-2026 Cumulative Revenue by Region, Value ($ mn) and Share (%)
Figure 51. North American Human Insulin Market, 2019-2026, $ mn
Figure 52. Breakdown of North America Human Insulin Market by Country, 2019 and 2026, % of Revenue
Figure 53. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 54. U.S. Human Insulin Market, 2019-2026, $ mn
Figure 55. Canada Human Insulin Market, 2019-2026, $ mn
Figure 56. European Human Insulin Market, 2019-2026, $ mn
Figure 57. Breakdown of European Human Insulin Market by Country, 2019 and 2026, % of Revenue
Figure 58. Contribution to Europe 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 59. Human Insulin Market in Germany, 2019-2026, $ mn
Figure 60. Human Insulin Market in UK, 2019-2026, $ mn
Figure 61. Human Insulin Market in France, 2019-2026, $ mn
Figure 62. Human Insulin Market in Spain, 2019-2026, $ mn
Figure 63. Human Insulin Market in Italy, 2019-2026, $ mn
Figure 64. Human Insulin Market in Rest of Europe, 2019-2026, $ mn
Figure 65. Asia-Pacific Human Insulin Market, 2019-2026, $ mn
Figure 66. Breakdown of APAC Human Insulin Market by Country, 2019 and 2026, % of Revenue
Figure 67. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 68. Human Insulin Market in Japan, 2019-2026, $ mn
Figure 69. Human Insulin Market in China, 2019-2026, $ mn
Figure 70. Human Insulin Market in Australia, 2019-2026, $ mn
Figure 71. Human Insulin Market in India, 2019-2026, $ mn
Figure 72. Human Insulin Market in South Korea, 2019-2026, $ mn
Figure 73. Human Insulin Market in Rest of APAC, 2019-2026, $ mn
Figure 74. Latin America Human Insulin Market, 2019-2026, $ mn
Figure 75. Breakdown of Latin America Human Insulin Market by Country, 2019 and 2026, % of Revenue
Figure 76. Contribution to Latin America 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 77. Human Insulin Market in Argentina, 2019-2026, $ mn
Figure 78. Human Insulin Market in Brazil, 2019-2026, $ mn
Figure 79. Human Insulin Market in Mexico, 2019-2026, $ mn
Figure 80. Human Insulin Market in Rest of Latin America, 2019-2026, $ mn
Figure 81. Human Insulin Market in Rest of the World (RoW), 2019-2026, $ mn
Figure 82. Breakdown of RoW Human Insulin Market by Country, 2019 and 2026, % of Revenue
Figure 83. Contribution to RoW 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 84. Human Insulin Market in UAE, 2019-2026, $ mn
Figure 85. Human Insulin Market in Saudi Arabia, 2019-2026, $ mn
Figure 86. Human Insulin Market in South Africa, 2019-2026, $ mn
Figure 87. Growth Stage of Global Human Insulin Industry over the Forecast Period
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Astra Zeneca PLC
  • Biocon
  • Eli Lilly
  • Exir
  • Julphar
  • Novo Nordisk AS
  • Pfizer
  • Sanofi Aventis
  • Sedico
  • Wockhardt
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll